SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zensar Technologies informs about completion of acquisition

25 Jul 2024 Evaluate
Further to its disclosure dated July 17, 2024, intimating entering into definitive agreement(s)/document(s) for acquisition of 100% membership interests in BridgeView Life Sciences, LLC, by Zensar Technologies Inc, USA (wholly owned subsidiary of the Company). Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and all other applicable provisions, Zensar Technologies has informed that acquisition of BridgeView Life Sciences, LLC has been completed on July 24, 2024.

The above information is a part of company’s filings submitted to BSE.

Zensar Technologies Share Price

603.00 14.75 (2.51%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2581.65
Infosys 1318.60
HCL Tech. 1442.50
Wipro 204.35
Tech Mahindra 1511.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×